It is unknown whether a first influenza vaccination protects high-risk adults from severe morbidity and mortality during influenza epidemics. As part of the PRISMA nested case-control study, we aimed to evaluate the effectiveness of first-time and repeat influenza vaccinations in adult persons recommended for vaccination aged between 18 and 64 years during the 1999-2000 influenza A epidemic. After adjustments, 69% of hospitalizations for acute respiratory or cardiovascular disease or death were prevented in first-time vaccinees (95% percent confidence interval [95% CI]: 8-90%). The corresponding figure in persons who were vaccinated before was 85% (95% CI: 36-96%). Adult persons with high-risk medical conditions can substantially benefit fr...
Background: The aim of the present study was to estimate the effectiveness of the MF59TM-adjuvanted ...
BACKGROUND: Evidence establishing effectiveness of influenza vaccination for prevention of severe il...
Hadigal et al. argued the recommendation of high-dose influenza vaccine over standard-dose formulati...
It is unknown whether a first influenza vaccination protects high-risk adults from severe morbidity ...
BackgroundSince 1960, the Advisory Committee on Immunization Practices (ACIP) has recommended influe...
BACKGROUND: Influenza vaccination has consistently been shown to prevent all-cause death and hospita...
BACKGROUND: Influenza vaccination has consistently been shown to prevent all-cause death and hospita...
BackgroundSeasonal influenza vaccination has been routinely recommended for adults with high-risk co...
Background:Annual influenza vaccination has been recommended for persons with high-risk conditions s...
BACKGROUND: Influenza vaccination has consistently been shown to prevent all-cause death and hospita...
BACKGROUND: Influenza vaccination has consistently been shown to prevent all-cause death and hospita...
The most effective strategy for preventing influenza is annual vaccination. We analyzed 2005-2011 da...
Vaccination remains the most effective way to prevent influenza infection, albeit vaccine effectiven...
Background:The aim of the present study was to estimate the effectiveness of the MF59™-adjuvanted in...
INTRODUCTION: Because of variability in published A(H1N1)pdm09 influenza vaccine effectiveness estim...
Background: The aim of the present study was to estimate the effectiveness of the MF59TM-adjuvanted ...
BACKGROUND: Evidence establishing effectiveness of influenza vaccination for prevention of severe il...
Hadigal et al. argued the recommendation of high-dose influenza vaccine over standard-dose formulati...
It is unknown whether a first influenza vaccination protects high-risk adults from severe morbidity ...
BackgroundSince 1960, the Advisory Committee on Immunization Practices (ACIP) has recommended influe...
BACKGROUND: Influenza vaccination has consistently been shown to prevent all-cause death and hospita...
BACKGROUND: Influenza vaccination has consistently been shown to prevent all-cause death and hospita...
BackgroundSeasonal influenza vaccination has been routinely recommended for adults with high-risk co...
Background:Annual influenza vaccination has been recommended for persons with high-risk conditions s...
BACKGROUND: Influenza vaccination has consistently been shown to prevent all-cause death and hospita...
BACKGROUND: Influenza vaccination has consistently been shown to prevent all-cause death and hospita...
The most effective strategy for preventing influenza is annual vaccination. We analyzed 2005-2011 da...
Vaccination remains the most effective way to prevent influenza infection, albeit vaccine effectiven...
Background:The aim of the present study was to estimate the effectiveness of the MF59™-adjuvanted in...
INTRODUCTION: Because of variability in published A(H1N1)pdm09 influenza vaccine effectiveness estim...
Background: The aim of the present study was to estimate the effectiveness of the MF59TM-adjuvanted ...
BACKGROUND: Evidence establishing effectiveness of influenza vaccination for prevention of severe il...
Hadigal et al. argued the recommendation of high-dose influenza vaccine over standard-dose formulati...